Yu Chong Zhang
Directeur/Membre du Conseil chez GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD.
Fortune : 170 M $ au 31/05/2024
Postes actifs de Yu Chong Zhang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 27/12/2019 | - |
| Corporate Officer/Principal | 06/12/2018 | - | |
Guangdong Eashu Pharmaceutical Co., Ltd.
 Guangdong Eashu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Guangdong Eashu Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of chemical agents, chemical raw materials, and Chinese medicines. It offers medicine in the form of tablets, capsules, and granules. It also provides active pharmaceutical ingredients such as etracaine hydrochloride, carbocisteine, tolbutamide, benzocaine, propafenone hydrochloride, and taurine. The company was founded on October 9, 2000 and is headquartered in Zhaoqing, China. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Yu Chong Zhang
Formation de Yu Chong Zhang
| The University of Manchester | Graduate Degree |
| Sun Yat-Sen University | Undergraduate Degree |
Statistiques
Internationale
| Chine | 4 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Guangdong Eashu Pharmaceutical Co., Ltd.
Guangdong Eashu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Guangdong Eashu Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of chemical agents, chemical raw materials, and Chinese medicines. It offers medicine in the form of tablets, capsules, and granules. It also provides active pharmaceutical ingredients such as etracaine hydrochloride, carbocisteine, tolbutamide, benzocaine, propafenone hydrochloride, and taurine. The company was founded on October 9, 2000 and is headquartered in Zhaoqing, China. | Health Technology |
- Bourse
- Insiders
- Yu Chong Zhang
- Expérience
